City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
220818
Name:
Closed Session - Settlement of Lawsuit - Endo
Health Solutions Inc., Endo Pharmaceuticals Inc.,
Par Pharmaceutical, Inc. and Par Pharmaceutical
Companies, Inc. - City to Receive $10,000,000 -
July 19, 2022
Status:
Type:
Hearing
Special Order
File created:
In control:
7/12/2022
Board of Supervisors
On agenda:
Final action:
7/19/2022
7/19/2022
Enactment date:
Enactment #:
Title:
Closed Session for the Board of Supervisors to convene on July 19, 2022, pursuant to California
Government Code, Section 54956.9(a), and San Francisco Administrative Code, Section 67.10(d)(1),
for the purpose of conferring with, or receiving advice from, the City Attorney regarding the following
existing litigation in which the City is a plaintiff: The City and County of San Francisco and the People
of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer
D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A.
Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals
L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo
International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals,
Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc,
Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis
Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and
McKesson Corporation; scheduled pursuant to the Motion contained in File No. 220816, to be
considered on July 19, 2022.
Sponsors:
Attachments:
1. Board Pkt 071922
Action By
Date
Action
Result
Ver.
SCHEDULED FOR PUBLIC HEARING
Clerk of the Board
7/12/2022
1
TABLED BY OPERATION OF LAW
Board of Supervisors
7/19/2022
1